Biotechnology Venture Capital Firms
The world of biotechnology is one filled with unlimited potential and opportunities. Built upon transformative innovations that have the strength to redefine industries, it comes as no surprise that it stands as a powerful magnet for venture capital (VC) firms keen on investing in the future. Welcome to VC Firms List, the one-stop destination for all detailed information on biotechnology venture capital firms. As you explore, you will discover why we are the go-to website for anyone seeking insights into the VC firms and investors specializing in the biotechnology sector.
Read moreCompany:
No 8 Ventures
Description: No 8 Ventures stands out as one of New Zealand's foremost investors specializing in early-stage technology companies. Their investment portfolio spans a diverse range of sectors, including biotechnology, information technology, medical devices, internet enterprises, and high-tech manufacturing. Notable investments by No 8 Ventures include pioneering companies such as Martin Aircraft Company, Open Cloud, Surveylab, Rex Bionics, Proacta, Right Hemisphere, PayGlobal, and Vertical Composting. Through its strategic focus and commitment to innovation, No 8 Ventures continues to play a significant role in fostering the growth of transformative technology solutions in New Zealand and beyond.
Industry: Venture Capital and Private Equity
Founded: 1998
Domain: http://www.no8ventures.co.nz/
Location: Wellington
Address: Wellington, 6011, NZ
Size: 2-10 employees
Company:
Palo Santo
Description: Palo Santo is at the forefront of creating a transformative future in mental wellness. Through its diversified investment fund, the company aims to significantly enhance the availability of clinically effective, affordable, and accessible treatment solutions for mental health and addiction in today's society. Recognizing the urgent need for such solutions, Palo Santo is leveraging a robust body of emerging evidence and strong support from the FDA to focus on psychedelic-assisted treatments, which represent a groundbreaking shift in mental health care.
The mental health landscape is characterized by a fragmented ecosystem of business opportunities, with a notable absence of institutional capital in the sector. In response to this challenge, Palo Santo strategically targets high-growth opportunities across various fields, including biotechnology, drug development, healthcare services, and digital health solutions. The firm is particularly interested in partnering with passionate, experienced, and ethical management teams that are committed to making a meaningful difference in the treatment of mental health conditions.
Through its investments, Palo Santo is poised to have a significant positive impact on the treatment of a range of conditions, including depression, PTSD, anxiety, OCD, substance dependence, chronic pain, Alzheimer's disease, and various inflammatory-related illnesses. By supporting innovative companies in these areas, Palo Santo is contributing to the advancement of mental health care and fostering a healthier future for individuals in need of effective treatments.
Industry: Venture Capital and Private Equity
Founded: 2020
Domain: http://www.palosanto.vc/
Location: Chicago & NYC
Address: Chicago & NYC, US
Size: 2-10 employees
Company:
Panacea Venture
Description: Panacea Venture is a distinguished life sciences venture capital firm that operates with a global vision, establishing a presence across three continents. Founded in 2017, the firm is currently managing four investment funds, which focus on early-stage companies through public investments. Panacea Venture is dedicated to incubating innovative early-stage companies that possess breakthrough technologies and discoveries aimed at addressing unmet medical needs. Their objective is to enhance the quality of life on a global scale.
The investment team at Panacea Venture boasts more than 100 years of combined investing experience. This wealth of expertise is further augmented by the contributions of venture partners and advisors, who collectively provide extensive coverage across both emerging and established sectors, including biotechnology, diagnostics, and medical technology (medtech). The highly experienced team at Panacea Venture has established a robust track record of successfully guiding portfolio companies toward their goals, ensuring that their innovative solutions reach those who can benefit from them. Through their commitment to fostering technological advancement in the life sciences, Panacea Venture continues to play a pivotal role in shaping the future of healthcare and improving lives worldwide.
Industry: Investment Management
Founded: 2017
Domain: http://www.panaceaventure.com/
Location: Silicon Valley
Address: Silicon Valley, US
Size: 11-50 employees
Company:
Pandect Bioventures
Description: Pandect Bioventures is a distinguished venture capital firm that specializes in providing funding opportunities for early-stage biotech and pharmaceutical companies. Focusing on investments ranging from seed funding to Series A and beyond, Pandect Bioventures is dedicated to supporting innovative entrepreneurs in the life sciences sector. In addition to financial backing, the firm offers comprehensive management support, which is designed to assist these companies in navigating the complexities of their industry and achieving essential business milestones. Through its strategic approach and commitment to fostering growth, Pandect Bioventures plays a vital role in advancing the development of groundbreaking solutions in biotechnology and pharmaceuticals.
Industry: Venture Capital and Private Equity
Founded: 2018
Domain: http://www.pandectbio.com/
Location: South San Francisco, California
Address: 280 Utah Ave, South San Francisco, California 94080, US
Size: 2-10 employees
Company:
Pure Ventures
Description: Pure Ventures is a California-based venture capital firm that focuses on early-stage investments, guided by a team of seasoned general partners and experienced operators. The firm strategically allocates its investment capital equally across two distinct areas: 50% is directed towards consumer sectors, which include consumer packaged goods (CPG), e-commerce, direct-to-consumer (D2C) brands, subscription services, and marketplaces. The remaining 50% is invested in a variety of technology sectors, demonstrating a broad sector-agnostic approach that encompasses fields such as Defense Technology, Energy, Biotechnology, Artificial Intelligence, Robotics, Aerospace, and innovations related to cryptocurrency and non-fungible tokens (NFTs).
Pure Ventures primarily seeks to invest in seed-stage companies that have successfully achieved product-market fit and possess a clear pathway to their Series A funding round. The firm aims to secure equity positions ranging from 3% to 5% in these promising ventures, with typical investments ranging between $500,000 and $1 million. This approach not only underscores Pure Ventures' commitment to fostering innovation but also highlights its ability to recognize and support businesses poised for significant growth and success in the marketplace.
Industry: Venture Capital and Private Equity
Domain: http://www.pureventuresvc.com/
Size: 2-10 employees
Company:
Qiming Venture Partners USA
Description: Qiming Venture Partners USA is a prominent healthcare venture capital firm established in 2017, dedicated to fostering the growth of innovative companies within the healthcare sector. With a strong emphasis on healthcare investment, the firm combines extensive technical expertise with substantial operational experience, enabling them to identify and support tomorrow's innovations in their infancy. This unique blend of skills positions Qiming Venture Partners USA as a preferred investor for early-stage biotech companies.
The firm's partners are highly sought after for their hands-on approach, which not only supports CEOs but also aids in scaling operations effectively. Their reputation as trusted business and thought partners adds significant value to the companies they engage with, ensuring a collaborative and supportive environment for growth. Each partner brings international experience, having worked and lived outside of the United States, which imbues Qiming Venture Partners USA with a genuinely global perspective.
One of the firm's standout advantages is its exclusive access to the Chinese market, recognized as the second-largest healthcare market in the world. This access enables Qiming Venture Partners USA to leverage its extensive networks throughout China and the broader Asian region, enhancing market diligence, deal flow, and operational support for its portfolio companies. By harnessing the rich backgrounds and diverse skill sets of its founders, along with a next-generation investment approach, Qiming Venture Partners USA is well-equipped to understand and capitalize on future innovations, facilitating strong connections with a wide array of crossover and public investors.
Industry: Venture Capital and Private Equity
Founded: 2017
Domain: http://www.qimingvcusa.com/
Location: Seattle, Washington
Address: Seattle, Washington 98121, US
Size: 11-50 employees
Company:
Revere Partners
Description: Revere Partners stands out as the pioneering venture capital fund dedicated exclusively to oral health. This innovative firm identifies promising opportunities for investors by providing essential capital for groundbreaking advancements in both oral and systemic health sectors. With a commitment to transforming the landscape of dental and systemic health ventures, Revere Partners brings together market awareness, business expertise, and the leading minds in the dental field to enhance innovations and optimize the experiences of both patients and providers.
As a strategic and active investor, Revere Partners possesses the flexibility to lead or participate in investment rounds, regardless of pricing structures. The firm is recognized as a thought leader within the industry, leveraging its unique blend of dental industry expertise and robust analytical research capabilities to forecast trends and uncover opportunities within the healthcare sector.
The founders, Dr. Jeremy Krell and David Arena, have assembled an exceptional management team of 25 professionals who are dedicated to connecting startups with key leadership across the dental ecosystem, including top dental chains, manufacturers, distributors, insurers, academia, professional associations, laboratories, and retailers nationwide. Revere Partners operates with a mission to educate and generate improved outcomes within the industry, amassing an unparalleled dataset of dental technology companies that underscores the importance of investing in Seed and Series A rounds.
Moreover, the firm has also reserved space in its portfolio for targeted opportunities, such as pre-seed investments and innovation competitions, alongside follow-on investments in Series B and subsequent funding rounds. Investment targets encompass a wide array of sectors, including software, fintech, technology diagnostics, dental services, biotechnology, consumer brands, payments, reimbursement, and access to care. By fostering unmatched strategic partnerships, Revere Partners aims to enhance care delivery and elevate the experiences of patients and providers, ultimately maximizing value for its investors.
Industry: Venture Capital and Private Equity
Domain: http://www.reverepartnersvc.com/
Location: New York , New York
Address: New York , New York 10027, US
Size: 2-10 employees
Company:
Robin Hood Ventures
Description: Robin Hood Ventures is a distinguished group of angel investors dedicated to identifying and supporting early-stage, high-growth companies within the Greater Philadelphia region. The firm plays a significant role in fostering entrepreneurship by providing a robust blend of capital, mentorship, expertise, and valuable connections, all aimed at helping businesses realize their full potential.
With a typical investment range of $250,000 to $500,000, Robin Hood Ventures collaborates closely with a diverse network of angels, institutions, and venture capitalists to enhance the growth opportunities for the companies in which they invest. This collaborative approach allows Robin Hood Ventures to invest as a unified entity in businesses they are knowledgeable about, ensuring that their investments are grounded in an understanding of the respective industries.
Since its inception in 1999, Robin Hood Ventures has made strategic investments in over 45 companies spanning various sectors, including software, medical devices, biotechnology, internet technology, and financial technology. The firm’s commitment to empowering entrepreneurs and elevating the business landscape in the Greater Philadelphia area reflects its long-standing dedication to nurturing innovative ventures that drive economic growth and create lasting value.
Industry: Venture Capital and Private Equity
Founded: 1999
Location: Philadelphia, PA
Address: 3711 Market Street, 8th Floor, Philadelphia, PA 19104, US
Size: 51-200 employees
Company:
S32
Description: S32 is a distinguished venture capital firm that specializes in investing at the cutting edge of technology. Established by Bill Maris, S32 boasts a team with extensive experience in fostering the growth of iconic companies. The firm's primary objective is to accelerate the discovery, development, and distribution of groundbreaking technologies aimed at enhancing the human condition.
S32's investment approach encompasses a broad spectrum of technological innovations, reflecting their commitment to advancing the frontiers of various sectors. Their investment portfolio includes areas such as artificial intelligence, enterprise software, cybersecurity, fintech, quantum computing, computational biology, and biotechnology. Through these diverse ventures, S32 seeks to play a pivotal role in shaping the future of technology for the betterment of society. For updates and insights, S32 can be followed on Twitter at http://twitter.com/S32_VC.
Industry: Venture Capital and Private Equity
Founded: 2017
LinkedIn: https://www.linkedin.com/company/s32vc
Domain: http://www.s32.com/
Location: Silicon Valley, CA
Address: Silicon Valley, CA, US
Size: 11-50 employees
Company:
S32
Description: S32 is a distinguished venture capital firm that specializes in investing at the forefront of technological innovation. Founded by Bill Maris, the firm boasts a team with extensive experience in nurturing and developing iconic companies. S32 is dedicated to accelerating the discovery, development, and distribution of groundbreaking technologies that aim to enhance the human experience.
Their investment strategy spans a wide array of technology sectors, reflecting their commitment to supporting advancements that have the potential to make a significant impact. This includes areas such as artificial intelligence, enterprise software, cybersecurity, fintech, quantum computing, computational biology, and biotechnology. S32’s multifaceted approach positions them as a key player in the venture capital landscape, fostering revolutionary technologies that can transform industries and improve lives. For those interested in following their journey, S32 maintains an active presence on Twitter.
Industry: Venture Capital and Private Equity
Founded: 2017
LinkedIn: https://www.linkedin.com/company/s32vc
Domain: http://www.section32.com/
Location: Silicon Valley, CA
Address: Silicon Valley, CA, US
Size: 11-50 employees
Company:
SANTÉ
Description: SANTÉ operates at the forefront of innovation within the Healthcare and Technology sectors, effectively managing a capital portfolio exceeding $800 million across two distinct strategies. SANTÉ Ventures focuses on investing in pioneering early-stage healthcare companies, specifically within the Biotech, Medtech, and Healthtech industries. Meanwhile, SANTÉ Capital employs advanced machine learning techniques integrated with established investment expertise to achieve favorable risk-adjusted returns through a systematic public equity strategy. Through these comprehensive investment approaches, SANTÉ is committed to fostering growth and development in cutting-edge healthcare solutions while delivering value to its stakeholders.
Industry: Venture Capital and Private Equity
Founded: 2006
Domain: http://www.sante.com/
Location: Austin, Texas
Address: 201 W 5th St, Suite 1500, Austin, Texas 78701, US
Size: 11-50 employees
Company:
SR One Capital Management
Description: SR One Capital Management is a transatlantic venture capital firm specializing in the biotechnology sector. The firm is dedicated to forming strategic partnerships with leading entrepreneurs, scientists, and investment partners who share a vision for building exceptional biotechnology companies. SR One Capital Management's mission centers around translating innovative technologies into potential next-generation medicines, aiming to address significant unmet medical needs in the patient community. With a presence in both San Francisco, California, and London, United Kingdom, SR One operates across key markets to leverage diverse opportunities within the biotech landscape. For further details, interested parties are encouraged to visit their website at www.srone.com.
Industry: Venture Capital and Private Equity
Founded: 2020
LinkedIn: https://www.linkedin.com/company/sr-one
Domain: http://www.srone.com/
Location: San Francisco, CA
Address: San Francisco, CA, US
Size: 11-50 employees
Company:
SV Health Investors
Description: SV Health Investors is a specialized fund manager focused on the healthcare sector, engaging in a broad range of investments across various stages, geographic regions, and industry sectors. With a particular emphasis on biotechnology, dementia, and healthcare growth, SV Health Investors leverages its extensive expertise to identify and support innovative companies that are shaping the future of healthcare. In addition to its core funds, the firm manages the Dementia Discovery Fund, which is dedicated to the discovery and development of novel therapeutics aimed at addressing the challenges posed by dementia. Through its strategic investments and targeted focus, SV Health Investors plays a vital role in advancing healthcare innovation and improving patient outcomes.
Industry: Venture Capital and Private Equity
Founded: 1993
Location: London, London
Address: First Floor, 71 Kingsway, Holborn, London, London WC2B 6ST, GB
Size: 51-200 employees
Company:
Saturn Partners
Description: Saturn Partners has established itself as a prominent player in the venture capital and private equity sector since its founding in 1993. The firm is recognized for its opportunistic investment strategy, which is characterized by a hands-on approach to identifying and nurturing promising opportunities in the seed and early-stage venture capital arenas. Primarily focusing on ventures in the Eastern United States, Saturn Partners specializes in a diverse range of sectors. Its investment portfolio predominantly features companies within information technology, financial technology, advanced materials, specialty energy, and selective biotechnology. This breadth of focus reflects Saturn Partners' commitment to harnessing innovative ideas and fostering growth in various high-potential industries.
Industry: Venture Capital and Private Equity
Founded: 1994
Domain: http://www.saturnpartnersvc.com/
Location: Boston, Massachusetts
Address: 75 Federal Street, Suite 1320, Boston, Massachusetts 02110, US
Size: 2-10 employees